|
N-(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoylethanolamine |
|
CHEBI:85252 |
|
N-(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoylethanolamine |
|
An N-acylethanolamine 22:6 that is the ethanolamide of (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoic acid. |
|
This entity has been manually annotated by the ChEBI Team.
|
|
Nevila Nouspikel
|
|
|
|
Molfile
XML
SDF
|
|
|
|
InChI=1S/C24H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-24(27)25-22-23-26/h3-4,6-7,9-10,12-13,15-16,18-19,26H,2,5,8,11,14,17,20-23H2,1H3,(H,25,27)/b4-3-,7-6-,10-9-,13-12-,16-15-,19-18- |
GEEHOLRSGZPBSM-KUBAVDMBSA-N |
CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(=O)NCCO |
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via endocannabinoid )
cannabinoid receptor agonist
An agonist that binds to and activates cannabinoid receptors.
(via cannabinoid )
|
|
View more via ChEBI Ontology
Outgoing
|
N-(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoylethanolamine
(CHEBI:85252)
has functional parent
all-cis-docosa-4,7,10,13,16,19-hexaenoic acid
(CHEBI:28125)
N-(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoylethanolamine
(CHEBI:85252)
is a
N-acylethanolamine 22:6
(CHEBI:134165)
N-(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoylethanolamine
(CHEBI:85252)
is a
endocannabinoid
(CHEBI:67197)
|
|
(4Z,7Z,10Z,13Z,16Z,19Z)-N-(2-hydroxyethyl)docosa-4,7,10,13,16,19-hexaenamide
|
Anandamide (22:6, n-3)
|
LIPID MAPS
|
N-(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl ethanolamine
|
UniProt
|
N-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-ethanolamine
|
LIPID MAPS
|
N-cis-4,7,10,13,16,19-docosahexanoylethanolamine
|
LIPID MAPS
|
7653452
|
Reaxys Registry Number
|
Reaxys
|
18227059
|
PubMed citation
|
SUBMITTER
|
|